InsiderSignalSign in
← Insider buys

Michael Geffner has sold IMVT and made no open-market buys since Jan 2024

Chief Medical Officer at Immunovant, Inc.

SEC CIK 0002007249 · Filings on SEC.gov ↗

$0Bought
$667KSold
NoneLast buy

Every filing

4 filings since Jan 2024, newest first

IMVTSell

Immunovant, Inc.

Chief Medical Officer

$94K−2.0%Oct 25
IMVTSell

Immunovant, Inc.

Chief Medical Officer

$96K−2.0%Jul 26
IMVTSell

Immunovant, Inc.

Chief Medical Officer

$94K−2.0%Apr 26
IMVTSell

Immunovant, Inc.

Chief Medical Officer

$383K−10.0%Jan 29

Filings come from SEC EDGAR. Not investment advice.